Crestor vs Losartan: Head-to-Head Efficacy for Women's Cardiometabolic Health
Rosuvastatin (Crestor) lowers LDL and CRP; losartan lowers blood pressure and protects kidneys. See how each drug works for women at every life stage.
Read clinical reviewTopic Hub
22 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.
Explore
Showing 22 of 22 clinical reviews.
Rosuvastatin (Crestor) lowers LDL and CRP; losartan lowers blood pressure and protects kidneys. See how each drug works for women at every life stage.
Read clinical reviewRosuvastatin vs evolocumab compared for women: LDL lowering, ASCVD risk, life-stage dosing, pregnancy safety, and when switching makes clinical sense.
Read clinical reviewCrestor cuts LDL up to 55%; Zetia cuts it ~18%. But which is safer in pregnancy, perimenopause, and PCOS? A women's-health breakdown.
Read clinical reviewLeqvio (inclisiran) vs amlodipine side-effect profile compared for women. LDL-lowering vs blood pressure. Life-stage, pregnancy, and PCOS guidance included.
Read clinical reviewComparing Leqvio (inclisiran) vs lisinopril side effects for women across life stages, including PCOS, perimenopause, pregnancy safety, and LDL-C data.
Read clinical reviewAtorvastatin vs inclisiran efficacy compared for women. Learn which lowers LDL more, how each works across life stages, and pregnancy/lactation safety.
Read clinical reviewAtorvastatin and losartan treat different cardiometabolic problems. This women-health guide compares cost, access, safety in pregnancy, and which drug fits your life stage.
Read clinical reviewAtorvastatin vs evolocumab compared for LDL lowering, cardiovascular outcomes, and women-specific safety including pregnancy, PCOS, and menopause.
Read clinical reviewLisinopril vs losartan side-effect profile compared for women, covering cough, angioedema, pregnancy risk, PCOS, menopause, and how to choose at every life stage.
Read clinical reviewComparing losartan vs amlodipine for women across every life stage, including who should switch, pregnancy safety, and hormone interactions.
Read clinical reviewPraluent (alirocumab) and lisinopril treat different cardiometabolic targets. Compare costs, evidence, and which option fits your life stage and risk profile.
Read clinical reviewAlirocumab (Praluent) cuts LDL up to 62%. Losartan lowers blood pressure and protects kidneys. Learn which drug fits your cardiometabolic risk, life stage, and hormonal status.
Read clinical reviewRepatha vs Leqvio side-effect profile compared for women. Covers injection-site reactions, pregnancy safety, life-stage dosing, and how to choose.
Read clinical reviewRepatha (evolocumab) and lisinopril treat different parts of cardiovascular risk. Learn how each works, what the trial data shows for women, and which fits your life stage.
Read clinical reviewRepatha (evolocumab) lowers LDL aggressively; lisinopril controls blood pressure. Learn when women switch, why, and what pregnancy and life stage mean for both.
Read clinical reviewRepatha and losartan treat different cardiometabolic risks. Compare costs, mechanisms, trial data, and women-specific considerations including pregnancy safety.
Read clinical reviewRepatha (evolocumab) lowers LDL up to 60%; losartan targets blood pressure and protects kidneys. Learn which is right for your life stage and cardiovascular risk.
Read clinical reviewRepatha and Praluent cut LDL by 50-60% and reduce MACE by 15%. See how they compare for women across life stages, including pregnancy safety.
Read clinical reviewCompare ezetimibe (Zetia) and losartan side-effect profiles for women across life stages, including pregnancy safety, PCOS, and menopause considerations.
Read clinical reviewZetia lowers LDL cholesterol; losartan lowers blood pressure. They treat different problems. Learn when each is right for you, and what switching means for your health.
Read clinical reviewEzetimibe (Zetia) costs under $30/month generic; alirocumab (Praluent) runs $500+ but cuts MACE 15%. See which cholesterol drug fits your life stage and budget.
Read clinical reviewZetia (ezetimibe) vs Repatha (evolocumab): LDL lowering, MACE outcomes, switching strategies, and pregnancy/lactation safety for women at every life stage.
Read clinical review